MedTrace Logo

Comparison of Outcomes of Multiple Platforms for Assisted Robotic - Prostate

NCT05766163 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 150

Last updated 2023-04-12

No results posted yet for this study

Summary

The object of this exploratory clinical trial is to evaluate post-operative complications in a population that underwent Robotic Assisted Radical Prostatectomy (RARP) made with multiple platforms:

* DaVinci;
* Hugo;
* Versius.

The questions it aims to answer are:

* Does the estimation of the post-operative complications suggest something?
* Are differences (intra-operative, post-operative, oncological, functional, technical, and economic) among the three intervention approaches observable?

Participants will be invited to fill out questionnaires and join one of these three groups:

1. surgery with the daVinci platform;
2. surgery with the Hugo platform;
3. surgery with the Versius platform.

Conditions

Interventions

DEVICE

DaVinci RARP

Assisted-robotic radical prostatectomy.

DEVICE

Hugo RARP

Assisted-robotic radical prostatectomy.

DEVICE

Versius RARP

Assisted-robotic radical prostatectomy.

Sponsors & Collaborators

  • Azienda Ospedaliera Universitaria Integrata Verona

    lead OTHER

Principal Investigators

  • Alessandro AA Antonelli · Azienda Ospedaliera Universitaria Integrata Verona

Study Design

Allocation
NON_RANDOMIZED
Purpose
OTHER
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
90 Years
Sex
MALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2023-03-14
Primary Completion
2024-03-31
Completion
2024-09-30
FDA Device
Yes

Countries

  • Italy

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05766163 on ClinicalTrials.gov